The endocannabinoid (eCB) system encompasses the eCBs anandamide and 2-
arachidonoylglycerol, their anabolic/catabolic enzymes, and the cannabinoid CB1 and CB2 …

The therapeutic benefits of the current medications for patients with psychiatric disorders
contrast with a great variety of adverse effects. The endocannabinoid system (ECS) …

Current first-line treatments for major depressive disorder (MDD), ie, antidepressant drugs
and psychotherapy, show delayed onset of therapeutic effect as late as 2–3 weeks or more …

Gene variation linked to physiological functions is recognised to affect elite athletic
performance by modulating training and competition-enabling behaviour. The fatty acid …

The endocannabinoid (eCB) system regulates many physiological functions in the central
nervous system. Fatty acid amide hydrolase (FAAH) is an essential enzyme in the eCB …

The endocannabinoid (eCB) system is an important neuromodulatory system with its
extensive network of receptors throughout the human body that has complex actions in the …

Electrical stimulation (ES) has been shown to improve some of impairments after spinal cord
injury (SCI), but the underlying mechanisms remain unclear. The Wnt signaling pathways …

Although an increasing number of patients suffering from mental illnesses self-medicate with
cannabis, current knowledge about the efficacy and safety of cannabis-based medicine in …

Genes encoding endocannabinoid and sphingolipid metabolism pathways were suggested
to contribute to the genetic risk towards attention deficit hyperactivity disorder (ADHD). The …

In this work, 2-AG was successfully detected in human plasma samples using a new
sandwich-type electrochemical immune device based on poly-β-cyclodextrin P (β-CD) …